These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8584928)

  • 1. Leishmania susceptibility puzzle gets another twist.
    Marx J
    Science; 1996 Feb; 271(5251):912-3. PubMed ID: 8584928
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Launois P; Himmelrich H; Tacchini-Cottier F; Milon G; Louis JA
    Microbes Infect; 1999 Jan; 1(1):59-64. PubMed ID: 10847767
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
    Heinzel FP; Maier RA
    Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development.
    Güler ML; Gorham JD; Hsieh CS; Mackey AJ; Steen RG; Dietrich WF; Murphy KM
    Science; 1996 Feb; 271(5251):984-7. PubMed ID: 8584935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunology of susceptibility and resistance to Leishmania major in mice.
    Sacks D; Noben-Trauth N
    Nat Rev Immunol; 2002 Nov; 2(11):845-58. PubMed ID: 12415308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
    Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
    Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis.
    Scott P; Hondowicz B; Eaton A; Scharton-Kersten T
    Ann N Y Acad Sci; 1996 Oct; 795():250-6. PubMed ID: 8958936
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to Leishmania major in mice.
    Demant P; Lipoldova M; Svobodova M
    Science; 1996 Nov; 274(5291):1392-3. PubMed ID: 8966604
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
    Titus RG; DeKrey GK; Morris RV; Soares MB
    Infect Immun; 2001 Aug; 69(8):5189-92. PubMed ID: 11447205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
    Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
    Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.
    Nabors GS; Nolan T; Croop W; Li J; Farrell JP
    Parasite Immunol; 1995 Nov; 17(11):569-79. PubMed ID: 8817603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B; Van Snick J; Brombacher F
    J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
    Noben-Trauth N; Paul WE; Sacks DL
    J Immunol; 1999 May; 162(10):6132-40. PubMed ID: 10229856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
    Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
    PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Leishmania major induced by tolerance to a single antigen.
    Julia V; Rassoulzadegan M; Glaichenhaus N
    Science; 1996 Oct; 274(5286):421-3. PubMed ID: 8832890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
    Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
    Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-MHC-linked genetic polymorphism controls selective development of Th2 but not inhibition of Th1 cells by soluble antigen administration.
    Galbiati F; Adorini L
    Microbes Infect; 1999 Jan; 1(1):73-7. PubMed ID: 10847769
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-13 is a susceptibility factor for Leishmania major infection.
    Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
    J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.